Masimo
MASI----
Masimo (MASI)
Masimo Corporation engages in the development, manufacture, and marketing of various patient monitoring technologies, and automation and connectivity solutions...
- Open
- --
- High
- --
- Low
- --
- Prev. Close
- --
- Volume
- --
- Turnover
- --
- Avg Price
- --
- Bid/Ask Ratio
- --
- Amplitude
- --
- 52wk High
- --
- Volume Ratio
- --
- Turnover Ratio
- --
Masimo Analyst Rating
View MoreForecast & Rating
May 2, 2026Price forecast
$180.000.03%
Forecast & RatingHold
8analysts
- Strong buy0.00%
- Buy0.00%
- Hold100.00%
- Sell0.00%
- Strong sell0.00%
News
- Quartr · 2 days ago, 09:07 AM
DHR: Raised 2026 guidance after strong Q2 results, robust orders, and successful Masimo acquisition
- benzinga_article · 2 days ago, 08:36 AM
Transcript: Danaher Q2 2026 Earnings Conference Call
- PUBT · 2 days ago, 05:02 AM
Danaher Q2 FY26 net earnings rise 60% to $870 million; revenue increases 5.5% to $6.3 billion
- CoinLive · Jul 16 at 01:11 PM
Danaher sees earnings lift from Masimo deal and bioprocessing rebound
- Unusual Whales · Jun 22 at 07:11 AM
Masimo Receives FDA 510(k) Clearance for AI-Enabled Opioid-Induced Respiratory Depression (OIRD) Detection on Radius VSM® to Help Identify Respiratory Risk Sooner
- PUBT · Jun 22 at 07:01 AM
Masimo wins FDA clearance for AI opioid respiratory depression detection on Radius VSM monitor
